The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Omega-3 Polyunsaturated Fatty Acid (Fish Oil) Supplementation and the Prevention of Clinical Cardiovascular Disease: A Science Advisory From the American Heart Association
Open accessAbstract
Multiple randomized controlled trials (RCTs) have assessed the effects of supplementation with eicosapentaenoic acid plus docosahexaenoic acid (omega-3 polyunsaturated fatty acids, commonly called fish oils) on the occurrence of clinical cardiovascular diseases. Although the effects of supplementation for the primary prevention of clinical cardiovascular events in the general population have not been examined, RCTs have assessed the role of supplementation in secondary prevention among patients with diabetes mellitus and prediabetes, patients at high risk of cardiovascular disease, and those with prevalent coronary heart disease. In this scientific advisory, we take a clinical approach and focus on common indications for omega-3 polyunsaturated fatty acid supplements related to the prevention of clinical cardiovascular events. We limited the scope of our review to large RCTs of supplementation with major clinical cardiovascular disease end points; meta-analyses were considered secondarily. We discuss the features of available RCTs and provide the rationale for our recommendations. We then use existing American Heart Association criteria to assess the strength of the recommendation and the level of evidence. On the basis of our review of the cumulative evidence from RCTs designed to assess the effect of omega-3 polyunsaturated fatty acid supplementation on clinical cardiovascular events, we update prior recommendations for patients with prevalent coronary heart disease, and we offer recommendations, when data are available, for patients with other clinical indications, including patients with diabetes mellitus and prediabetes and those with high risk of cardiovascular disease, stroke, heart failure, and atrial fibrillation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“There is a lack of evidence that OM3FA treatment reduces CV events in patients with hypertriglyceridemia of any severity, as recently reviewed by Siscovick and colleagues [8].”
From Omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid and their mechanisms of action on apolipoprotein B-containing lipoproteins in humans: a review (2017) · cites this paper as [8]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The American Heart Association scientific statements currently recommend n-3 PUFA supplements for secondary prevention of coronary heart disease 15 and in management of hypertriglyceridemia 16 .”
From Effects of n-3 Fatty Acid Supplements in Elderly Patients After Myocardial Infarction (2021) · cites this paper as [15]
In the citing paper
“However, reduction in atherosclerosis in animal models or humans by administration of OM3FAs has not been convincingly demonstrated [8, 11].”
In the citing paper
“Based on the latest meta-analysis (17) and American Heart Association Scientific Statement (18), there is modest support for their use.”
From Cardiovascular Impact of Nutritional Supplementation With Omega-3 Fatty Acids (2021) · cites this paper as [18]
In the citing paper
“Despite extensive interest and research, there is a lack of consistent support for OM-3 dietary supplements in CV risk reduction.”
From Critical Differences Between Dietary Supplement and Prescription Omega-3 Fatty Acids: A Narrative Review (2020) · cites this paper as [23]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fish Consumption, Fish Oil, Omega-3 Fatty Acids, and Cardiovascular Disease
Kris-Etherton, P. M., Harris, W. S., & Appel, L. J. (2002) · Circulation · doi:10.1161/01.cir.0000038493.65177.94 · Cited by 3,707
Self-citationBurr, M. L., Gilbert, J. F., Holliday, R. M., Elwood, P. C., Fehily, A. M., Rogers, S., Sweetnam, P. M., & Deadman, N. M. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90828-3 · Cited by 2,610
Yokoyama, M., Origasa, H., Matsuzaki, M., Matsuzawa, Y., Saito, Y., Ishikawa, Y., Oikawa, S., Sasaki, J., Hishida, H., Itakura, H., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60527-3 · Cited by 2,516
(1999) · PubMed · Cited by 2,062
Fish Intake, Contaminants, and Human Health: Evaluating the Risks and the Benefits
Mozaffarian, D., & Rimm, E. B. (2006) · JAMA · doi:10.1001/jama.296.15.1885 · Cited by 1,966
Self-citationTriglycerides and Cardiovascular Disease: A Scientific Statement From the American Heart Association
Miller, M., Stone, N. J., Ballantyne, C., Bittner, V., Criqui, M. H., Ginsberg, H. N., Goldberg, A. C., Howard, W. J., Jacobson, M. S., Kris-Etherton, P. M., et al. (2011) · Circulation · doi:10.1161/cir.0b013e3182160726 · Cited by 1,871
Self-citationOmega-3 Fatty Acids and Cardiovascular Disease
Mozaffarian, D., & Wu, J. H. Y. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.06.063 · Cited by 1,771
Self-citationGISSI-HF investigators (2008) · The Lancet · doi:10.1016/s0140-6736(08)61239-8 · Cited by 1,350
Marchioli, R., Barzi, F., Bomba, E., Chieffo, C., Di Gregorio, D., Di Mascio, R., Franzosi, M. G., Geraci, E., Levantesi, G., Maggioni, A. P., et al. (2002) · Circulation · doi:10.1161/01.cir.0000014682.14181.f2 · Cited by 1,311
Cited by
Sorted by citations
Items 601–629 of 629
Weerakkody, N., & Cheema, S. K. (2024) · Advances in biochemistry in health and disease · doi:10.1007/978-3-031-75686-3_21
Functionality of Supplements and Anti-aging: Functionality of Supplements—Cardiovascular
Shinmura, K. (2024) · Springer eBooks · doi:10.1007/978-981-97-8514-8_119
Nutrition Therapy for Children and Adolescents with Type 1 and Type 2 Diabetes
(2025) · American Academy of PediatricsItasca, IL eBooks · doi:10.1542/9781610027700-ch28
İçer, M. A., Yıldıran, H., Şahinarslan, A., & Topal, S. (2025) · Food Science & Nutrition · doi:10.1002/fsn3.70460
Colombo, S. M., Carr, J., & Gillis, C. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5370473
Colombo, S. M., Carr, J., & Gillis, C. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5370469
Performance of carboxymethylation of deacetylated glucomannan in stabilizing oil in water emulsion
Wardhani, D. H., Devara, H. R., Ulya, H. N., Kumoro, A. C., & Vázquez, J. A. (2025) · Food and Bioproducts Processing · doi:10.1016/j.fbp.2025.09.001
Ghalamara, S., Salsinha, A. S., Ujong, A., Pintado, M., & Tiwari, B. K. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-28810-4.00018-9
Kowalczyk, P., Sobol, M., Makulska, J., Węglarz, A., Kurylczyk, A., Schabikowski, M., & Skiba, G. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262110676
Global burden of ischemic heart disease due to omega-3 deficiency: 204-country analysis, 1990–2021
Chen, X., Chen, L., Yang, X., & Zhang, Z. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1658775
In vitro release behaviour of spray dried flaxseed oil Microcapsules for application in food system
Shahid, M. Z., Imran, M., Khan, M. K., & Hussain, A. I. (2019) · International Journal of Biosciences (IJB) · doi:10.12692/ijb/14.5.205-216
Zhou, L., Jiang, Y., Lin, Z., Chen, R., Niu, Y., & Kan, H. (2022) · Figshare · doi:10.6084/m9.figshare.21432971
Saad, R. A., Hasan, R. A., Qutob, H. M., Ali, H. S., Elayate, W. M., & Saad, D. A. (2025) · Journal of Evolutionary Biochemistry and Physiology · doi:10.1134/s1234567825600191
Chhay, P., Zhu, D., Tang, O., Gray, M. P., Vernon, S. T., Bartolo, B. A. D., Kott, K. A., Grieve, S. M., Gibson, R. A., Psaltis, P. J., et al. (2026) · Scientific Reports · doi:10.1038/s41598-026-36845-z · Cited by 1
Dual improvement effects of ω-3 on bone loss and liver injury in rats with liver–bone axis damage
Huang, J., Chen, L., Yu, H., Zhou, S., Guan, J., & Xu, C. (2026) · Food & Function · doi:10.1039/d6fo00026f
Health benefit considerations for the development of fish advisory guidelines for PFOS
Spliethoff, H. M., Palmer, M. C., Marquez‐Bravo, L. G., Marks, T., & Ginsberg, G. (2026) · Journal of Toxicology and Environmental Health Part B · doi:10.1080/10937404.2026.2665431 · Cited by 1
Panchali, T., Kar, R., Das, P., Dutta, A., Phoujdar, M., Ghosh, K., & Pradhan, S. (2026) · Metabolites · doi:10.3390/metabo16060384
Atrial fibrillation and sudden cardiac death in women
Cuk, N., & Sandhu, R. K. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-45863-7.00064-0
Youssim, I., Israel, S., Siscovick, D. S., Hochner, H., & Friedlander, Y. (2026) · American Journal of Clinical Nutrition · doi:10.1016/j.ajcnut.2026.101426
Self-citationLiu, D., Guo, Y., Li, G., Yang, C., Xiong, J., Deng, S., & Chen, R. (2026) · Healthcare · doi:10.3390/healthcare14152296
Harnessing the potential of polyunsaturated fatty acids for health and sustainable food systems
Sanjana, R., Sujithra, S., Krithiga, K. S., Kabeer, S., Krishnamoorthy, K., & Karthik, P. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-43810-3.00022-1
Egalini, F., Riccio, E., Grasso, M., Nelva, A., & Geronimo, V. D. (2026) · Nutrients · doi:10.3390/nu18152538
Sari, A., Soegianto, A., Afifudin, A. F. M., Agustin, N., & Imamah, S. W. (2026) · Springer proceedings in earth and environmental sciences · doi:10.1007/978-3-032-23955-6_10
Liu, L., Niu, W., Jia, Y., Zhang, Q., Dai, T., Li, D., Song, S., Ma, Y., Wang, J., 余焕玲, et al. (2026) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2026.08.010
Wattick, R. A., McNabb, T. B., & Hudson, A. (2026) · Current Diabetes Reports · doi:10.1007/s11892-026-01644-3
Sydora, B. C., Ghosh, M., Chambers, S., Haase, A., Davenport, M. H., Beaulieu, C., Thompson, R. B., Windram, J., Becher, H., Raggi, P., et al. (2026) · BMJ Open · doi:10.1136/bmjopen-2026-124025
Pietzner, A., Rohwer, N., & Weylandt, K. H. (2026) · medRxiv · doi:10.64898/2026.09.21.26363464
Hu, F. B., Beleslin, B., Blaha, M. J., Kris-Etherton, P. M., Seligman, H. K., & Williams, K. A. (2026) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2026.08.025
Self-citation
Metadata
- Authors
- Siscovick, D. S., Barringer, T. A., Fretts, A. M., Wu, J. H. Y., Lichtenstein, A. H., Costello, R. B., Kris-Etherton, P. M., Jacobson, T. A., Engler, M. B., Alger, H. M., Appel, L. J., & Mozaffarian, D.
- ORCID
- Venue
- Circulation
- Published
- 2017-04-11
- Volume
- 135
- Issue
- 15
- Pages
- e867-e884
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- PMC
- PMC6903779
- OpenAlex
- W2597054569
- Cited by
- 629
- References
- 52
- Citations by year
- 2026: 21 · 2025: 42 · 2024: 57 · 2023: 57 · 2022: 64 · 2021: 66 · 2020: 90 · 2019: 90 · 2018: 100 · 2017: 40
- FWCI
- 9.00
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Circulation (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Heart, Lung, and Blood Institute (R01HL101236, R01HL085710)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Nutritional Studies and Diet
- Physical Sciences › Chemistry › Organic Chemistry › Edible Oils Quality and Analysis
- Keywords
- omega-3 polyunsaturated fatty acids, fish oil supplementation, eicosapentaenoic acid, docosahexaenoic acid, cardiovascular disease prevention, secondary prevention, coronary artery disease, diabetes mellitus, prediabetes, high cardiovascular risk, stroke, heart failure, atrial fibrillation
- MeSH terms
- Atrial Fibrillation, Cardiovascular Diseases, Diabetes Mellitus, Fish Oils, Heart Failure, Cardiac Surgical Procedures, Humans, Primary Prevention, Risk, Fatty Acids, Omega-3, Dietary Supplements, Stroke, Diabetes Complications, Secondary Prevention
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
